Vericel (VCEL) Cost of Revenue (2011 - 2026)

Vericel has disclosed Cost of Revenue across 16 years of filings, most recently posting $19.2 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $19.2 million, up 17.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $73.5 million (up 12.18% YoY), and the FY2025 annual result was $70.7 million, up 8.51% from the prior year.
• Cost of Revenue came in at $19.2 million for Q1 2026 at Vericel, down from $19.8 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $19.8 million in Q4 2025 to a low of $12.6 million in Q1 2022.
• The 5-year median for Cost of Revenue is $16.1 million (2024), against an average of $16.0 million.
• Across the five-year window, Cost of Revenue rose 0.5% in 2024 and increased 17.36% in 2026, its largest moves.
• Vericel's Cost of Revenue stood at $14.4 million in 2022, then climbed by 14.15% to $16.5 million in 2023, then rose by 2.35% to $16.9 million in 2024, then climbed by 17.26% to $19.8 million in 2025, then slipped by 3.19% to $19.2 million in 2026.
• The last three Cost of Revenue figures came in at $19.2 million (Q1 2026), $19.8 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.